Stamaril Injection

Stamaril injection contains active components as Yellow fever vaccine. It is a crucial immunization that protects against the yellow fever virus. Yellow fever is a viral disease transmitted to humans through the bite of infected mosquitoes, primarily the Aedes aegypti mosquito. The primary benefit of this vaccine is its ability to prevent the potentially life-threatening disease caused by the yellow fever virus. Vaccinated individuals are far less likely to contract yellow fever when exposed to the virus. When a significant portion of the population is immune to the virus, it reduces the overall risk of transmission, protecting vulnerable individuals who cannot receive the vaccine due to medical reasons. A single dose of this vaccine typically provides long-lasting immunity for many years, often for a lifetime. The vaccine helps reduce the burden on healthcare systems by preventing yellow fever cases.

The Stamaril injection is typically administered via a single subcutaneous (under the skin) injection. This administration route allows the vaccine to enter the bloodstream and stimulate the immune system to develop protection against the yellow fever virus. It is a standard practice to administer the vaccine just under the skin, usually in the upper arm.

Stamaril injection belongs to the group of medications called ‘immunising agents’ used for the prevention of a serious infectious disease called yellow fever in adults, adolescents, and children. Stamaril injection contains yellow fever virus1 17D-204 strain (live, attenuated) that helps the body to develop immunity by stimulating the immune system to produce antibodies against yellow fever.

COLD CHAIN

1 PREFILLED SYRINGE